• A low-cost, high-yield production pillar that ensurestreatment sustainability and access

• Significant pricing and marketing flexibility to leveraging future market engagements

• Utilized a proprietary buffer system that enables efficient viral extraction

• Conventional way requires -80°C / lyophilization

• Proprietary formulation allows -20°C, offering enhanced flexibility in product storage and transportation.

• Engineered host cell lines to support stable and efficient manufacturing

• Utilizing bioreactors for upstream processing enables rapid future scale-up of production capacity

• Optimized chromatographic technique to improve purity and yields

• Stable at 4℃ for storage and transportation, and ready-to-use at room temperature